EGRX
|
Eagle Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
EDIT
|
Editas Medicine, Inc.
|
0.01%
|
US
|
NASDAQ
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
DCGO
|
DocGo Inc.
|
0.01%
|
US
|
NASDAQ
|
CUTR
|
Cutera, Inc.
|
0.01%
|
US
|
NASDAQ
|
CTKB
|
Cytek Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
CSTL
|
Castle Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
CSII
|
Cardiovascular Systems, Inc.
|
0.01%
|
US
|
NASDAQ
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.01%
|
US
|
NASDAQ
|
CLOV
|
Clover Health
|
0.01%
|
US
|
NASDAQ
|
CHRS
|
Coherus BioSciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
CERS
|
Cerus Corporation
|
0.01%
|
US
|
NASDAQ
|
CDXS
|
Codexis, Inc.
|
0.01%
|
US
|
NASDAQ
|
CDNA
|
CareDx, Inc.
|
0.01%
|
US
|
NASDAQ
|
CARA
|
Cara Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
CANO
|
Cano Health, Inc.
|
0.01%
|
US
|
NYSE
|
BNGO
|
Bionano Genomics, Inc.
|
0.01%
|
US
|
NASDAQ
|
BLFS
|
BioLife Solutions, Inc.
|
0.01%
|
US
|
NASDAQ
|
BFLY
|
Butterfly Network, Inc.
|
0.01%
|
US
|
NYSE
|